icals, (Piscataway, NJ) . LPS W extracted from Escherichia coli 0111 :114 was obtained from Difco Laboratories, Inc . (Detroit, MI) and was used at 20 tug/ml in all experiments . rIL-4, kindly provided by Immunex Corp ., Seattle, WA, was obtained from a yeast expression system using the alcohol dehydrogenase 2 promoter and the a-factor gene leader sequence to direct synthesis and secretion . The material was used in the form of a yeast cell supernatant that had an activity of 250,000 U/ml . Unitage was measured, by Immunex, in an anti-IgM costimulation assay in which 1 U of activity was equal to 5 pg of purified IL-4 (13) . Purified T cell-derived IL-4, kindly provided by Dr . Junichi Ohara of this laboratory, was used in some experiments . This material was derived from EL-4 cells by induction with PMA and was purified to homogeneity by affinity chromatography and reverse-phase HPLC (14) . Monoclonal rat IgGI anti-IL-4 antibody (IIBI1) (15) was purified from ascitic fluid by ammonium sulfate precipitation, passage over a DEAE cellulose column, followed by Sephadex G200 gel filtration . To remove any residual mouse IgGI, the anti-IL-4 antibody preparation was adsorbed over a 20 .10 .9 .1 column (monoclonal mouse IgG2a [b allotype] anti-mouse IgGI [a allotype]) (16) . Monoclonal rat IgGI anti-NP antibody (J4 .1) was a kind gift from Dr . R . Coffman from DNAX (Palo Alto, CA) and was similarly purified from ascites and used as a control for 111111 .
Preparation ofB Cells. Enriched populations of B cells were obtained from spleen cells from which T cells had been eliminated by the method of Leibson et al . (17) . Small, dense B cells were separated by the modified (18) discontinuous Percoll-gradient centrifugation procedure of DeFranco et al . (19) . Cells forming a band between 66 and 70% Percoll and having a density of 1 .081-1 .086 g/ml were considered to be resting B cells and were used in all experiments .
Cell Cultures . Functional assays were carried out in 96-well flat-bottom plates (Costar, Cambridge, MA) in a 200-ul final volume . Plates were incubated at 37°C in a humidified 6% C02 atmosphere . DNA synthesis was determined by [ s H]thymidine uptake (2 yCi/well ; 6 .7 Ci/nmol ; 1 mCi = 37GBq ; ICN K & K Laboratories Inc ., Irvine, CA) over a 6-h period . Cells were harvested onto glass filter paper and [ s H]thymidine incorporation was determined by liquid scintillation spectrometry . For preincubation experiments, resting B cells were cultured in 25-cm 2 tissue culture flasks (Corning Glass Works, Corning, NY) at 2 .5 x 10 5 cells/ml in the presence of LPS and IL-4 (600 or 10,000 U/ml) for 48 h . Cells were then washed three times in cold HBSS, counted, and replated into 96-well flatbottom plates (Costar) for further analysis .
Measurement of Ig Isotype Concentrations in Culture Supernatants. Ig isotype concentrations were measured by an ELISA using Immulon 2, 96-well flat-bottomed ELISA plates (Dynatech Laboratories, Inc ., Alexandria, VA) and has been described by us in detail elsewhere (11) . Briefly, a fluorescent product, generated from cleavage of 4-methyl umbilliferyl phosphate (Sigma Chemical Co ., St . Louis, MO) by specifically bound alkaline phosphatase-conjugated antibodies, was quantitated on a fluorometer (Allergenetics, a division of Axonics, Inc ., Mountain View, CA) . Fluorescence units were converted to Ig concentrations by extrapolation from standard curves, determined using purified myeloma proteins of known concentration . Each assay system showed no significant cross-reactivity or interference from the concentration of other isotypes (IgM, IgD, IgG3, IgGI, IgG2b, IgG2a, IgE, IgA) found in the culture supernatants . For some IgGI determinations in which high concentrations of anti-IL-4 (111111) and anti-NP (J4 .1) antibodies were present in culture supernatants, ELISA wells were coated with the monoclonal anti-IgGI antibody, 20 .10 .9 .1 . The 11 B 11 and J4 .1 preparations had been adsorbed on a 20 .10 .9 .1 column . After addition of culture supernatants and standards and washing, polyclonal rabbit anti-mouse IgG I (20) was added followed by alkaline phosphatase goat anti-rabbit IgG (21) . In this assay, 1 mg/mI of either 111111 or J4 .1 scored as 100 ng/ml of IgGI (0 .01 %) which was too low to influence the measurements of IgG 1 concentrations in the culture supernatants . were stimulated with LPS and increasing concentrations of rIL-4. Production of Ig of various isotypes was measured on the sixth day of culture. The IL-4 dose/IgGI response curve was strikingly bimodal (Fig. 1) . IgGI levels peak at IL-4 concentrations between 40 and 160 U/ml to levels of^" 18.5 ug/ml compared with 1 ug/ml in cells stimulated with LPS alone. However, with increasing IL-4 concentrations, IgG1 levels progressively decline reaching a nadir at -1,000 U/ml (3 .0 Mg/ml) . A further increase in IL-4 concentration to 10,000 U/ml results in a progressive rise in the level of IgGI to 15 .0 jAg/ml .
The amount of IgE appearing in these cultures rises progressively with increasing IL-4 concentrations reaching a concentration of 4 .2 ,ug/ml at 10,000 U/ml compared with <0.001 ttg/ml in cells stimulated with LPS alone (Fig. 1) . At IL-4 concentrations at which IgG1 secretion reaches its first peak (40-160 U/ml), IgE levels, although substantially above those obtained with LPS alone, are only 2% of maximal. No suppression of IgE production at intermediate IL-4 concentrations is observed . The amount of IL-4 needed for optimal IgE secretion is similar to that required for the second peak for IgG 1 production and is 100-fold higher than that needed for the first peak of IgGI production.
As IL-4 concentrations are increased, IgM and IgG3 ( Fig. 1 ) and IgG2b and IgG2a production (Table I) show progressive, marked declines over amounts obtained with LPS stimulation only . Significant degrees of suppression of these isotypes are generally seen at IL-4 levels at which the initial peak IgGI secretion is obtained (40-160 U/ml). Maximal degrees of suppression, ranging from 95 to 98% for these isotypes, were observed at 300-600 U IL-4/ml. Concentrations of IL-4 up to 10,000 U/ml fail to enhance either IgA or IgD secretion over the undetectable levels seen with LPS stimulation only (data not shown) .
We also studied Ig production by B cells stimulated with LPS and purified T cell-derived IL-4, in concentrations from 10 to 1,000 U/ml . We observed both the initial peak and nadir of IgG 1 production, stimulation in IgE production, and suppression of IgM, IgG3, IgG2b, and IgG2a (data not shown), confirming that both recombinant and T cell-derived IL-4 have similar functions.
Anti-IL-4 Antibody Reverses Both the Enhancement and Suppression of Ig Isotype
Secretion by IL-4. Monoclonal anti-IL-4 antibody was used to assess whether the dramatic changes in Ig isotype secretion induced by IL-4 in LPS-stimulated B cell cultures was an effect of IL-4 itself and not of some possible contaminant. An isotype-matched mAb (J4.1) was used as a control. The cells were stimulated with LPS and 600 U/ml of IL-4, a concentration which yields a nadir in the IgG1 response curve. Addition of increasing concentrations of anti-IL-4 Ab to cultures stimulated with LPS and 600 U IL-4 initially produced a rise in IgGI levels and then a progressive decline to levels similar to those obtained in cultures to which LPS but no IL-4 had been added (Fig. 2) . Addition of J4.1 had no effect . This result indicates that both the first peak and the nadir in the IL-4 dose/IgGI response curve is due to IL-4 and not to some possible contaminant in the IL-4 preparation .
The addition of 600 U IL-4/ml caused a 94% diminution in IgM secretion. Addition of increasing amounts of anti-IL-4 produced a steady rise in IgM concentrations approaching that observed in response to LPS alone indicating that the suppressive effect of IL-4 on IgM production is also an effect of IL-4.
In a separate experiment, we evaluated the capacity of anti-IL-4 to inhibit IgE production in response to LPS and 10,000 U/ml of IL-4. Cells stimulated with LPS only produced <0.001 hg/ml of IgE. Addition of 10,000 U IL-4/ml gave 4 jug IgE/ml . Addition of increasing amounts of anti-IL-4 to these cultures caused a progressive decline in IgE concentrations to 0.009 leg/ml whereas addition of J4 .1 at similar concentrations had no effect (Fig. 2) . In this experiment, we also measured IgGI production in response to 10,000 U/ml of IL-4, the concentration that causes the second peak of IgGI . Anti-IL-4 inhibited this response whereasJ4.1 had no effect (data not shown) . These results indicate that even for effects that require very large amounts of the IL-4 preparation, the active entity is IL-4. levels decreased from 28 .1-5.1 jug/ml (82% suppression) as IL-4 was increased from 125-600 U/ml, despite no change in cell yield or [3H]thymidine incorporation . Finally, the highest IgE levels (1 .9,ug/ml) and the second IgGI peak (16.2 jug/ml) occurred at an IL-4 concentration of 10,000 U/ml where cell yield and [3H]thymidine incorporation were at their lowest levels . Hence, the degree of suppression observed for IgM, IgG3, and IgGl, and the level of enhancement for IgE and the second rise in IgG 1 cannot be explained simply by an overall change in cell numbers or [3H]thymidine incorporation . Short-term Exposure of B Cells to IL-4 Causes Maximal Production of IgGI. B cells were cultured with LPS and either 100 or 600 U/ml of IL-4 . To terminate the action of the lymphokine, anti-IL-4 was added on various days of culture. All supernatants were removed 6 d after the initiation of culture for determination of Ig isotype concentrations . Addition of anti-IL-4 at the outset of culture completely blocks the stimulation of IgGI (Fig. 4) and of IgE and the inhibition of IgM (data not shown) .
Delaying the addition of anti-IL-4 by 2 d results in IgGl production in response to 100 U/ml of IL-4 equivalent to that obtained if IL-4 was present for the entire culture period . By contrast, stimulating B cells with 600 U/ml of IL-4 for only the first 2 d caused greater production of IgGI than was observed with either 600 or 100 U/ml of IL-4 present for the entire culture (Fig. 4) . Indeed, the presence of 600 U/ml of IL-4 for the entire 6-d culture period consistently leads to the lowest levels of IgGI in the bimodal response to the lymphokine while 100 U/ml represents one of the two maxima of the IL-4 dose/IgGI response curve. This "hyperstimulatory" effect of 600 U/ml of IL-4 is lost if the addition of anti-IL-4 antibody is delayed until day 3; the presence of this concentration of IL-4 for an additional day causes a marked diminution in the amount of IgGI produced, to levels below that stimulated by 100 U/ml IL-4. This suggests that short-term exposure of B cells to IL-4 leads to heightened stimulation for IgGI production and that longer exposure to high concentrations is suppressive. Distinctive IL-4 Regulation of1gG1 and IgE Production. The striking diminution in IgGI production observed when the neutralization of 600 U/ml of IL-4 was delayed from day 2 to 3 of culture indicates that the presence of high concentrations of IL-4 "late" in culture is suppressive for IgGI production. To examine this in greater detail both for IgG1 and IgE production, B cells were cultured for 2 d with LPS and either 600 or 10,000 U/ml of IL-4 (Fig. 5) . The cells were then washed and replated at 3 X 10' cells/0 .2 ml with LPS and varying IL-4 concentrations . Culture supernatants were removed for measurement of Ig isotype concentrations after an additional 4 d in culture . B cells cultured with LPS and 600 U/ml of IL-4 for 2 d produced large amounts of IgGI when cultured for the remaining 4 d in LPS alone. The addition of up to 37 .5 U/ml of IL-4 at day 2 had no effect on IgGI production. Higher concentrations of IL-4 suppressed IgGI production; the greatest degree of suppression was obtained at 600 U/ml . 10,000 U/ml, although still suppressive, nonetheless led to the production of considerably more IgG 1 than that obtained with 600 U/ml during the second phase of culture. This indicates that very high concentrations of IL-4 are less suppressive than intermediate concentrations during the final 4 d of culture.
Culture of B cells with LPS and 10,000 U/ml of IL-4 for the initial 2 d of culture results in the production of IgGI in amounts similar to that observed for cells cultured with 600 U/ml for the first 2 d. Furthermore, cells initially cultured with 10,000 U/ml are as sensitive to subsequent suppression by IL-4 as those initially cultured with 600 U/ml of IL-4. From this experiment, we conclude that the difference in IgGI production in response to 600 and 10,000 U/ml for the entire culture period is due to differences in the late "suppressive" period rather than in the initial "preparatory" period of culture.
Examination of IgE production in this system revealed that cells prepared with IL-4 and LPS for 2 d produced very small amounts of IgE (30-50 ng/ml) at 6 d when cultured in LPS alone for the final 4 d of culture. The presence of IL-4 during the final 4 d of culture stimulated additional IgE production in a dosedependent manner. In contrast to results for IgG 1, no suppression is observed ; the amount of IgE produced rises as the concentration of IL-4 present during the final 4 d of culture rises, reaching a maximum (>3 .5 Ecg/ml) at 10,000 U/ml . If no IL-4 is present during the initial 2 d of culture, IgE is not produced in response to addition of even very large amounts of IL-4 during the final 4 d of culture (data not shown) . Thus, the presence of IL-4 with LPS during the initial 2 d of culture is essential for IgE production. Furthermore, 600 U/ml of IL-4 is as effective as 10,000 U/ml for this preparatory effect, indicating that the requirement of very high concentrations of IL-4 to obtain substantial IgE production reflects a need for such concentrations in the late part of the culture. Discussion IL-4 is a T cell-derived lymphokine that had been previously shown to selectively enhance IgGI and IgE production and to suppress IgG3 and IgG2b secretion by murine B lymphocytes stimulated by LPS (1-6, 12 ). Initial studies, while contributing greatly to our knowledge of IL-4-induced regulation of Ig isotype secretion, were limited by the use of crude IL-4-containing supernatants . More recent studies have used purified T cell-derived or rIL-4 but at relatively low concentrations . In the current study, we examined the effects of IL-4 over a much wider concentration range than previously used (up to 10,000 U/ml [^"50 ng/ml]). This has allowed us to observe several properties of IL-4 in the regulation of Ig isotype secretion by LPS-stimulated B cells that had not been previously noted and that may be of considerable physiologic significance . Among these are (a) the IL-4-induced increase in IgGI secretion shows a bimodal doseresponse relationship ; (6) increasing IL-4 concentrations to 10,000 U/ml causes a progressive, marked increase in IgE secretion (>5,000-fold enhancement) to levels >25-fold higher than previously reported ; and (c) IL-4 causes a marked suppression of IgM and IgG2a secretion as well as of IgG3 and IgG2b production. Measurement of cell yields and of [sH]thymidine uptake indicates that both stimulation of IgGI and IgE and inhibition of Ig of other isotypes cannot be explained by any general effects on cell proliferation .
Our analysis of both the amounts of IL-4 required and the duration of IL-4 stimulation indicate that control of IgG 1 and IgE production is quite distinct . Optimal IgGI secretion can be achieved by substantially lower concentrations (^-100-fold) and a shorter time of exposure to IL-4 than that required for high level IgE secretion.
In light of striking changes in Ig isotype secretion at very high IL-4 concentrations, it was important to determine whether these effects were due to IL-4 or to some possible contaminant. Experiments using the monoclonal anti-IL-4 antibody (11 B 11) demonstrate unambiguously that IL-4 was critical to all effects described. Furthermore, using T cell-derived IL-4 purified by affinity chromatography and reverse-phase HPLC, we observe similar suppression of IgM, IgG3, IgG2b, and IgG2a, as well as IgGI and stimulation of IgE at a dose of 1,000 U/ml. The finding that IL-4 obtained from two distinct sources have similar effects on Ig isotype production and that these effects are blocked by monoclonal anti-IL-4 antibody indicates that the pattern o£ regulation observed is an intrinsic property of IL-4 .
One may question the physiological significance of effects seen at such high doses of IL-4. It is quite probable that IL-4 can be delivered to its specific receptor on the B cell surface through intimate physical contact with an IL-4-secreting T cell in an antigen-specific, histocompatibility-restricted fashion. Kupfer et al . have shown that helper T cells align their microtubular-organizing complex and Golgi apparatus toward the contact surface of a linked antigenpresenting cell (22) . Within the confines of the "synaptic junction" which forms between interacting T and B cells, it is conceivable that lymphokines could be "focused" at very high local concentrations at the surface of the antigen-presenting B cell surface.
It is of great interest that the same lymphokine, IL-4, controls the expression of two different Ig isotypes, IgGI and IgE, but that the dose-response curve and time course for this regulation differ strikingly between the two. IgG 1 production in response to LPS and IL-4 displays a bimodal dose-response curve. The first peak of IgG 1 production occurs at a concentration of IL-4^" 100-fold lower than that required for maximal IgE secretion; the latter, however, is similar to that required for the second peak of IgGI production . (The second peak occurs at the highest IL-4 concentrations used in these experiments and is thus not necessarily the maximal level that could be achieved . However, in a limited number of experiments, 30,000 U/ml caused substantial cell death, precluding analysis of the effect of concentrations above 10,000 U/ml). Furthermore, the inhibition of IgGI production by the addition of IL-4 to B cells that have been cultured for 2 d with LPS and IL-4 has a complex dose-response curve with intermediate concentrations (>100 U/ml) showing striking inhibition of IgGI production but with very high concentrations (10,000 U/ml) actually causing less inhibition . Although this may reflect IL-4 regulation of a single population of precursors of IgGI-producing cells, it could also be explained by the existence of two populations of precursors of IgGI-producing cells, one stimulated by a low concentration of IL-4 and inhibited by intermediate to high concentrations and a second with IL-4 concentration requirements identical to the precursors of IgE-producing cells. This putative second population of IgGI producers may also share with the IgE precursors the requirement for a longer duration of exposure to IL-4 and a failure to be inhibited by late addition of IL-4. Indeed, it is conceivable that there is a common precursor for the "high-dose IgGI producers" and for the IgE producers.
The finding that 2-d exposure of B cells to LPS and IL-4 prepares them for maximal IgGI responses and that concentrations of 600 and 10,000 U/ml are equally effective for preparation stands in contrast to the dose-dependent inhibition of IgGI production when additional IL-4 is added to these cells after 2 d of culture. The mechanism underlying the inhibitory effects of "late" IL-4 addition on IgGI production are unknown. A "two-phase" control of IgE synthesis is also seen, although it is different from the two-phase control of IgGI production. Incubation of resting B cells with LPS and either 600 or 10,000 U/ml of IL-4 for 2 d prepares these cells, equally well, to secrete large amounts of IgE if 10,000 U/ml are added to culture after 2 d. Thus, for IgE synthesis, the initial phase is relatively concentration independent, just as the initial phase for IgGI production; the late phase requires a high concentration of IL-4 for IgE production whereas the late presence of IL-4 is inhibitory for IgGI production .
The finding that IL-4 controls both IgGI and IgE production is not surprising since they share important biological properties . Both are capable of binding to mast cells and mediating degranulation (23) and both are able to mediate antibody-dependent cellular cytotoxicity by eosinophils for certain parasitic targets (24, 25) . IgE, however, is considerably more efficient for mast cell degranulation (23) .
In addition, IL-4 is capable of acting as a costimulant for the growth of mast cells (26, 27) and upregulates the receptor for the Fc portion of IgE on B cells (28, 29) . It has also been demonstrated that T cell lines, designated TH2 lines, capable of secreting IL-4 also secrete IL-5 (30, 31 ; also West, J., F. Carding, R. Rasmeussen, A. Woods, T. Honjo, and K. Bottomly, manuscript submitted for publication) . IL-5 has been shown to have growth-promoting properties for eosinophils (32, 33) . Finally, it has been recently demonstrated that IL-4 is a potent costimulant for the growth of multiple hematopoietic precursors (34) . The selective activation of TH2 cells by certain parasitic agents, therefore, would allow for a coordinated host response for parasite elimination that would include IL-4 and IL-5 release and the stimulation of IgGI and IgE secretion. Further-more, the suppression of secretion of other isotypes may be important in limiting the concentrations of antibodies that compete for antigenic determinants on the "target" but are unable to initiate an appropriate effector function.
On the other hand, the control of IgGI and IgE are clearly not identical. In vivo, these Igs occur at vastly different concentrations and the frequencies of IgGI-and IgE-secreting cells are enormously different (7) . Our results indicate that the regulation of IgGI and IgE production by IL-4 are not the same . The concentration of IL-4 required to achieve the production of large amounts of IgE is much greater than concentration of IL-4 that is adequate for striking stimulation of IgG 1 production.
Monoclonal anti-IL-4 antibody strikingly blocks the increase in serum IgE levels in mice inoculated with the parasitic nematode Nippostrongylus brasiliensis and in mice stimulated with anti-IgD antibodies while it has little or no effect on increases in serum IgGI levels (7). This suggests either that larger amounts of IL-4 are required for IgE than IgGI production in vivo or that IgE production is exclusively dependent upon IL-4 while IgGI production may be stimulated by other mechanisms . In either case, the results argue for a differential regulation of IgGI and IgE production in vivo, just as we have demonstrated for their in vitro regulation . Other examples of such distinctive regulation are the striking induction of IgE in helminth-infected mice with only a moderate increase in IgGI concentrations (7) and the observation that early in the course of rat schistosomal infections, the predominant protective Ig isotype is the "anaphylactic" rat IgG, IgG2a, while later in the course of the disease, protection is mainly afforded by IgE (35) . In view of the very different potencies of murine IgE and IgGI as anaphylactic antibodies, such distinctive regulation would seem most appropriate. Summary IL-4/B cell stimulatory factor-I is a T cell-derived lymphokine that has been shown to enhance IgGI and IgE and to suppress IgG3 and IgG2b secretion by B cells stimulated with bacterial LPS. We show here that the stimulation of IgGI and IgE secretion in response to rIL-4 is differentially regulated. The doseresponse curve for IgGI production is bimodal with peaks at 100 and 10,000 U/ml. IgE production is modest at 100 U/ml and exhibits a progressive enhancement as the IL-4 concentration is increased to 10,000 U/ml, reaching^" 1 lAg of IgE from an initial cell number of 2 X 104 . Both of these effects are reversed by monoclonal anti-IL-4 antibody . Neither the enhancing nor suppressing effects of IL-4 can be explained by changes in viable cell yields or [sH]thymidine incorporation . The production of both IgGI and IgE is controlled by IL-4 in a two-phase manner. During the initial 2 d of culture with LPS, IL-4 action for both IgGI and IgE production is relatively concentration independent at doses >600 U/ml . This 2-d treatment leads to maximal IgGI production at day 6 with no further addition of IL-4. Addition of IL-4 during the final 4 d of culture has no effect at concentrations under 100 U/ml . At higher concentrations, IL-4 is strikingly suppressive for IgGI production. By contrast, little IgE is produced unless IL-4 is present after 2 d of culture and the response is directly dependent on the concentration of IL-4 during this second phase of culture with maximal responses observed at 10,000 U/ml . These differences in IL-4 requirements for IgGl and IgE production, respectively, may have an important role in the regulation of the synthesis of these isotypes in responses to microbial antigens .
